Cell Encapsulation Membrane with Mitigation Layer for Oxygen Diffusion

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current cell encapsulation devices face challenges in maintaining immune isolation while allowing sufficient blood vessel formation close to the implanted cells, which is essential for oxygen and nutrient delivery, as the immune response triggered by foreign bodies hinders vascularization.

Innovation Solution

A biocompatible membrane composite with a cell impermeable layer and a mitigation layer, where the mitigation layer has solid features with a majority of solid feature spacing less than 50 microns, porosity greater than 50%, and a thickness less than 200 microns, designed to minimize foreign body giant cell formation and promote vascular ingrowth, thereby optimizing oxygen diffusion for cell survival and function.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Reliability

If a cell encapsulation device is implanted to provide immune isolation, then immune protection of cells is improved, but foreign body giant cell formation increases which prevents blood vessel formation close to cells

Engineering Contradiction:
Improveimmune protectionVSAvoidforeign body response
Core Design Contradiction:
ReliabilityVSObject-affected harmful factors

Solution Approach 1:

The encapsulation device is segmented into multiple functional layers: an inner cell impermeable layer for immune isolation, an outer porous layer for vascular ingrowth, and intermediate mitigation layers with specific solid feature spacings to control foreign body responses. This segmentation allows each layer to perform its specialized function without interfering with others.

Inventive Principle:
Principle #1Segmentation

Solution Approach 2:

The porous outer layer acts as an intermediary between the immune-protective inner layer and the host tissue. It allows blood vessels to form within its structure and extends capillaries close to the cell impermeable layer, mediating the conflict between immune isolation and nutrient delivery.

Inventive Principle:
Principle #24Intermediary (Mediator)

2Reliability

If the diffusion distance for oxygen is reduced to improve cell viability, then cell survival is improved, but the device structure becomes more complex

Engineering Contradiction:
Improvecell viabilityVSAvoiddevice structure
Core Design Contradiction:
ReliabilityVSDevice complexity

Solution Approach 1:

The outer porous layer with controlled pore sizes and solid feature spacings less than 50 microns allows oxygen and nutrients to diffuse efficiently to the cell impermeable layer while maintaining structural integrity. The porous structure naturally reduces diffusion distances without requiring complex active transport mechanisms.

Inventive Principle:
Principle #31Porous materials

3Productivity

If blood vessels are allowed to form close to encapsulated cells to improve nutrient delivery, then cell productivity is improved, but immune isolation is compromised

Engineering Contradiction:
Improvecell productivityVSAvoidimmune isolation
Core Design Contradiction:
ProductivityVSReliability

Solution Approach 1:

Different regions of the encapsulation device have different properties: the inner layer is cell impermeable for immune isolation, while the outer layer is porous to allow vascular ingrowth. This local differentiation of properties allows immune protection in one region while enabling nutrient delivery in another.

Inventive Principle:
Principle #3Local quality

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

The solution effectively reduces foreign body responses, allowing for close proximity of blood vessels to the encapsulated cells, enhancing their viability and ability to secrete therapeutically useful substances by minimizing oxygen diffusion distance and ensuring nutrient delivery.

Implementation Method 1

the diffusion distance and time needed for transport of the oxygen and nutrients to the implanted, encapsulated cells is minimized

Methodology Applied
Scientific EffectDiffusion: Diffusion

Implementation Method 2

the second layer has a second porosity greater than about 60%

Methodology Applied
Scientific EffectPorosity: Porosity

Data Source

PatentUS20220233299A1Cell encapsulation devices with controlled oxygen diffusion distances
Publication Date: 2022.07.28 VIACYTE INC
  • US20220233299A1 patent drawing
  • US20220233299A1 patent drawing
  • US20220233299A1 patent drawing

AI summary

Cell encapsulation devices for biological entities and/or cell populations that contain at least one biocompatible membrane composite are provided. The cell encapsulation devices mitigate or tailor the foreign body response from a host such that sufficient blood vessels are able to form at a cell impermeable surface. Additionally, the encapsulation devices have an oxygen diffusion distance that is sufficient for the survival of the encapsulated cells so that the cells are able to secrete a therapeutically useful substance. The biocompatible membrane composite is formed of a cell impermeable layer and a mitigation layer. The cell encapsulation device maintains an optimal oxygen diffusion distance through the design of the cell encapsulation device or through the use of lumen control mechanisms. Lumen control mechanisms include a reinforcing component that is also a nutrient impermeable layer, internal structural pillars, internal tensioning member(s), and/or an internal cell displacing core.